Sirolimus for Cowden Syndrome With Colon Polyposis

Key facts

Sponsor

Ohio State University

Principal Investigator

Peter P Stanich, MD

Ohio State University

Intervention

Sirolimus(drug)

Enrollment

5 enrolled

Eligibility

18-80 years · All sexes

Timeline

2019 – 2025

Study locations (1)

• The Ohio State University Wexner Medical Center, Columbus, Ohio, United States

Collaborators

PTEN Research · Pfizer

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Other trials for PTEN hamartoma tumor syndrome

Additional recruiting or active studies for the same condition.

• RECRUITINGNCT06805734
  Natural History With Focus on Oncological Risk Evaluation in Pediatric Patients With PTEN Pathogenic Variants
  Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta
• RECRUITINGNCT06462430
  PTEN Hamartoma Tumor Syndrome Pediatric Patient Registry
  Yale University

See all trials for PTEN hamartoma tumor syndrome →